Skip to main content
Fig. 4 | Molecular Medicine

Fig. 4

From: The novel transcriptomic signature of angiogenesis predicts clinical outcome, tumor microenvironment and treatment response for prostate adenocarcinoma

Fig. 4

The analyses of clinical features between high- and low-ARGs signature score groups in PRAD cohort. A Boxplots representing age of diagnosis for high- and low-ARGs signature score groups (p = 0.092). B Boxplots of the PSA level between high- and low ARGs signature score groups (p = 0.005). C Percentage-staked bar plot representing patient distribution with Gleason primary + secondary score between high- and low-ARGs signature score groups (p < 0.001). D Percentage-staked bar plot representing tumor stage (T1/T2/T3/T4/NA) between high- and low-ARGs signature score groups (p < 0.001). E Percentage-staked bar plot representing lymph node status (N0/N1//NA) (p < 0.001) between high- and low-ARGs signature score groups (p < 0.001). F Percentage-staked bar plot representing tumor metastasis (M0/M1//NA) between high- and low-ARGs signature score groups (p = 0.12). (NA not applicable)

Back to article page

Molecular Medicine

ISSN: 1528-3658